Clinical Trials List
2018-09-01 - 2026-10-02
Phase III
Not yet recruiting1
Recruiting4
ICD-9238.7
Neoplasm of uncertain behavior of other lymphatic and hematopoietic tissues
-
Trial Applicant
PPD DEVELOPMENT (HK) LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 田豐銘 Division of Hematology & Oncology
- MING YAO Division of Hematology & Oncology
- - - Division of Hematology & Oncology
- Huai-Hsuan Huang Division of Hematology & Oncology
- - - Division of Hematology & Oncology
- Chieh-Lung Cheng Division of Hematology & Oncology
- Wen-Chien Chou Division of Others -
- 李思慧 Division of Hematology & Oncology
- Shang-Ju Wu Division of Hematology & Oncology
- 徐思淳 Division of Others
- Jih-Luh Tang Division of Hematology & Oncology
- CHENG-HONG TSAI Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Audit
None
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Tzu-Ting Chen Division of Hematology & Oncology
- Ming-Hung Tsai Division of Hematology & Oncology
- Che-Hung Lin Division of Hematology & Oncology
- Ming-Yu Lien Division of Hematology & Oncology
- Ching-Chan Lin Division of Hematology & Oncology
- Ching Yun Hsieh Division of Hematology & Oncology
- Chi-Ching Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 騰傑林 Division of Hematology & Oncology
- Tsung -Chih Chen Division of Hematology & Oncology
- CHENG-HSIEN LIN Division of Hematology & Oncology
- YU-HSUAN SHIH Division of Hematology & Oncology
- 滕傑林 Division of Hematology & Oncology
- HSIN-CHEN LIN Division of Hematology & Oncology
- ZHENG-WEI ZHOU Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
Audit
None
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
350 participants